Hi DocJ - Would you mind forwarding this to Joe
Post# of 36563
(Total Views: 294)
Posted On: 10/06/2020 2:21:23 PM
Re: Paul Jackson #22139
Hi DocJ -
Would you mind forwarding this to Joe? Not sure if GNBT is thinking of SPAC or would like to use a SPAC?
Thank you so much!
A special purpose acquisition company (SPAC) is a shell company that raises money through an initial public offering (IPO) in order to take a company public through acquisition. Companies that want to go public usually go the route of an IPO; however, SPACs have risen in popularity recently due to their ability to get to market faster and surging demand from investors.
It can take months for a company to debut on the public markets the old fashioned way. The IPO process requires that companies work with underwriters and regulators to produce and approve a detailed investor prospectus. Additionally, the companies need to go on an "IPO roadshow" to pitch their shares to dozens of early investors.
On the other hand, going public via SPAC enables a company to get a deal done in weeks -- instead of months -- and only requires the selling company to negotiate with a single investor that controls the SPAC. Commonly referred to as a "blank-check company," a SPAC jumps through the pre-IPO hoops and goes public itself instead of the target company, which is ultimately acquired with the funds raised from the markets. More recently, biotech companies have started to embrace the SPAC structure too.
https://ih.advfn.com/stock-market/USOTC/gener...ech-market
Generex Biotechnology (GNBT) is a OTC biotech worth some attention. GNBT is a Phoenix strategy rising from the ashes of a NASDAQ crash. The company is loaded with proven IP and big pharma relationships. With the SPAC buzz bringing attention to the Biotech market, GNBT could deliver big returns at any moment.
Read More: https://investorshangout.com/post/newpost/622...z6a7I7kvxe
Would you mind forwarding this to Joe? Not sure if GNBT is thinking of SPAC or would like to use a SPAC?
Thank you so much!
A special purpose acquisition company (SPAC) is a shell company that raises money through an initial public offering (IPO) in order to take a company public through acquisition. Companies that want to go public usually go the route of an IPO; however, SPACs have risen in popularity recently due to their ability to get to market faster and surging demand from investors.
It can take months for a company to debut on the public markets the old fashioned way. The IPO process requires that companies work with underwriters and regulators to produce and approve a detailed investor prospectus. Additionally, the companies need to go on an "IPO roadshow" to pitch their shares to dozens of early investors.
On the other hand, going public via SPAC enables a company to get a deal done in weeks -- instead of months -- and only requires the selling company to negotiate with a single investor that controls the SPAC. Commonly referred to as a "blank-check company," a SPAC jumps through the pre-IPO hoops and goes public itself instead of the target company, which is ultimately acquired with the funds raised from the markets. More recently, biotech companies have started to embrace the SPAC structure too.
https://ih.advfn.com/stock-market/USOTC/gener...ech-market
Generex Biotechnology (GNBT) is a OTC biotech worth some attention. GNBT is a Phoenix strategy rising from the ashes of a NASDAQ crash. The company is loaded with proven IP and big pharma relationships. With the SPAC buzz bringing attention to the Biotech market, GNBT could deliver big returns at any moment.
Read More: https://investorshangout.com/post/newpost/622...z6a7I7kvxe
(0)
(0)